Chemokine axes in hematopoietic stem cell mobilization

[1]  H. Broxmeyer,et al.  SDF‐1/CXCL12 Enhances Survival and Chemotaxis of Murine Embryonic Stem Cells and Production of Primitive and Definitive Hematopoietic Progenitor Cells , 2005, Stem cells.

[2]  J. Dipersio,et al.  The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone. , 2005, Blood.

[3]  H. Broxmeyer,et al.  Transforming growth factor-{beta}1 modulates responses of CD34+ cord blood cells to stromal cell-derived factor-1/CXCL12. , 2005, Blood.

[4]  H. Broxmeyer,et al.  Stromal cell-derived factor-1/CXCL12 selectively counteracts inhibitory effects of myelosuppressive chemokines on hematopoietic progenitor cell proliferation in vitro. , 2005, Stem cells and development.

[5]  Christie M. Orschell,et al.  Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist , 2005, The Journal of experimental medicine.

[6]  B. Wood,et al.  Augmented mobilization and collection of CD34+ hematopoietic cells from normal human volunteers stimulated with granulocyte–colony‐stimulating factor by single‐dose administration of AMD3100, a CXCR4 antagonist , 2005, Transfusion.

[7]  D. Wong,et al.  The CXCR4 agonist peptide, CTCE-0021, rapidly mobilizes polymorphonuclear neutrophils and hematopoietic progenitor cells into peripheral blood and synergizes with granulocyte colony-stimulating factor. , 2005, Experimental hematology.

[8]  D. Link,et al.  Disruption of SDF-1/CXCR4 Signaling during Flt-3 Ligand and Stem Cell Factor (SCF) Induced Hematopoietic Progenitor Mobilization. , 2004 .

[9]  H. Broxmeyer,et al.  Enhancement of cell survival by stromal cell-derived factor-1/CXCL12 involves activation of CREB and induction of Mcl-1 and c-Fos in factor-dependent human cell line MO7e. , 2004, Stem Cells and Development.

[10]  H. Broxmeyer,et al.  Modulation of Hematopoietic Stem Cell Homing and Engraftment by CD26 , 2004, Science.

[11]  T. Betsuyaku,et al.  Characterization of hematopoietic progenitor mobilization in protease-deficient mice. , 2004, Blood.

[12]  D. Wong,et al.  Small peptide analogs to stromal derived factor-1 enhance chemotactic migration of human and mouse hematopoietic cells. , 2004, Experimental hematology.

[13]  L. Madero,et al.  Hematopoietic stem cell transplantation using umbilical cord blood progenitors: review of current clinical results , 2004, Bone Marrow Transplantation.

[14]  B. Wood,et al.  Leukocytosis and Mobilization of CD34+ Hematopoietic Progenitor Cells by AMD3100, a CXCR4 Antagonist. , 2004, Supportive cancer therapy.

[15]  D. Wong,et al.  Rational Design of Chemokine SDF-1 Analogs with Agonist Activity for the CXCR4 Receptor and the Capacity to Rapidly Mobilize PMN and Hematopoietic Progenitor Cells in Mice , 2004 .

[16]  J. Dipersio,et al.  Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  T. Papayannopoulou.  Current mechanistic scenarios in hematopoietic stem/progenitor cell mobilization. , 2004, Blood.

[18]  H. Broxmeyer,et al.  CD26 is essential for normal G-CSF-induced progenitor cell mobilization as determined by CD26-/- mice. , 2003, Experimental hematology.

[19]  B. Wood,et al.  Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. , 2003, Blood.

[20]  S. Fruehauf,et al.  It's moving day: factors affecting peripheral blood stem mobilization and strategies for improvement , 2003 .

[21]  D. Link,et al.  G-CSF treatment induces a significant decrease in CXCL12 mRNA expression in the bone marrow , 2003 .

[22]  E. Clercq.  The bicyclam AMD3100 story , 2003, Nature Reviews Drug Discovery.

[23]  H. Broxmeyer,et al.  Cell surface peptidase CD26/DPPIV mediates G-CSF mobilization of mouse progenitor cells. , 2003, Blood.

[24]  H. Broxmeyer,et al.  Stromal cell‐derived factor‐1/CXCL12 directly enhances survival/antiapoptosis of myeloid progenitor cells through CXCR4 and Gαi proteins and enhances engraftment of competitive, repopulating stem cells , 2003, Journal of leukocyte biology.

[25]  J. Lévesque,et al.  Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. , 2003, The Journal of clinical investigation.

[26]  H. Broxmeyer,et al.  Transgenic Expression of Stromal Cell-Derived Factor-1/CXC Chemokine Ligand 12 Enhances Myeloid Progenitor Cell Survival/Antiapoptosis In Vitro in Response to Growth Factor Withdrawal and Enhances Myelopoiesis In Vivo , 2003, The Journal of Immunology.

[27]  H. Broxmeyer,et al.  Cell Surface Peptidase CD26/Dipeptidylpeptidase IV Regulates CXCL12/Stromal Cell-Derived Factor-1α-Mediated Chemotaxis of Human Cord Blood CD34+ Progenitor Cells1 , 2002, The Journal of Immunology.

[28]  D. Link,et al.  G-CSF is an essential regulator of neutrophil trafficking from the bone marrow to the blood. , 2002, Immunity.

[29]  O. Kollet,et al.  The essential roles of the chemokine SDF-1 and its receptor CXCR4 in human stem cell homing and repopulation of transplanted immune-deficient NOD/SCID and NOD/SCID/B2mnull mice , 2002, Leukemia.

[30]  E. De Clercq,et al.  Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4 , 2002, FEBS letters.

[31]  S. Cooper,et al.  Peripheral blood stem cell mobilization. A role for CXC chemokines. , 2002, Critical reviews in oncology/hematology.

[32]  C. Figdor,et al.  Enhancement of G-CSF-induced stem cell mobilization by antibodies against the beta 2 integrins LFA-1 and Mac-1. , 2002, Blood.

[33]  R. Taichman,et al.  G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4 , 2002, Nature Immunology.

[34]  A. Gotoh,et al.  Enhancement of intracellular signaling associated with hematopoietic progenitor cell survival in response to SDF-1/CXCL12 in synergy with other cytokines. , 2002, Blood.

[35]  D. Leduc,et al.  Leukocyte Elastase Negatively Regulates Stromal Cell-derived Factor-1 (SDF-1)/CXCR4 Binding and Functions by Amino-terminal Processing of SDF-1 and CXCR4* , 2002, The Journal of Biological Chemistry.

[36]  D. Link,et al.  Mechanisms of mobilization of hematopoietic progenitors with granulocyte colony-stimulating factor , 2002, Current opinion in hematology.

[37]  B. Williams,et al.  Mobilization by either cyclophosphamide or granulocyte colony-stimulating factor transforms the bone marrow into a highly proteolytic environment. , 2002, Experimental hematology.

[38]  A. Mantovani,et al.  Neutrophils are indispensable for hematopoietic stem cell mobilization induced by interleukin-8 in mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[39]  M. Le Bousse-Kerdilès,et al.  Stromal cell-derived factor 1 regulates primitive hematopoiesis by suppressing apoptosis and by promoting G(0)/G(1) transition in CD34(+) cells: evidence for an autocrine/paracrine mechanism. , 2002, Blood.

[40]  L. Bendall,et al.  The chemokine receptor CXCR4 enhances integrin-mediated in vitro adhesion and facilitates engraftment of leukemic precursor-B cells in the bone marrow. , 2001, Experimental hematology.

[41]  C. Overall,et al.  Matrix Metalloproteinase Activity Inactivates the CXC Chemokine Stromal Cell-derived Factor-1* , 2001, The Journal of Biological Chemistry.

[42]  David A. Williams,et al.  Mobilization and collection of peripheral blood CD34+ cells from patients with Fanconi anemia. , 2001, Blood.

[43]  S. Nilsson,et al.  Vascular cell adhesion molecule-1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor. , 2001, Blood.

[44]  S. Rafii,et al.  Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. , 2001, Blood.

[45]  S. Rafii,et al.  Mobilization of Endothelial and Hematopoietic Stem and Progenitor Cells by Adenovector‐Mediated Elevation of Serum Levels of SDF‐1, VEGF, and Angiopoietin‐1 , 2001, Annals of the New York Academy of Sciences.

[46]  A. Nagler,et al.  Rapid and efficient homing of human CD34(+)CD38(-/low)CXCR4(+) stem and progenitor cells to the bone marrow and spleen of NOD/SCID and NOD/SCID/B2m(null) mice. , 2001, Blood.

[47]  D. Scadden,et al.  CXCR-4 Desensitization Is Associated with Tissue Localization of Hemopoietic Progenitor Cells1 , 2001, The Journal of Immunology.

[48]  A. Farese,et al.  Rapid mobilization of murine hematopoietic stem cells with enhanced engraftment properties and evaluation of hematopoietic progenitor cell mobilization in rhesus monkeys by a single injection of SB-251353, a specific truncated form of the human CXC chemokine GRObeta. , 2001, Blood.

[49]  L. Scott,et al.  Synergistic mobilization of hemopoietic progenitor cells using concurrent β1 and β2 integrin blockade or β2-deficient mice , 2001 .

[50]  F. Prósper,et al.  Chemokine stromal cell-derived factor-1alpha modulates VLA-4 integrin-dependent adhesion to fibronectin and VCAM-1 on bone marrow hematopoietic progenitor cells. , 2001, Experimental hematology.

[51]  M. Baggiolini,et al.  Rapid inactivation of stromal cell‐derived factor‐1 by cathepsin G associated with lymphocytes , 2001, European journal of immunology.

[52]  D. Schenkein,et al.  A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin's disease or non-Hodgkin's lymphoma , 2000, Bone Marrow Transplantation.

[53]  C. Murdoch,et al.  Chemokine receptors and their role in inflammation and infectious diseases. , 2000, Blood.

[54]  M. Remberger,et al.  Faster engraftment of neutrophils and platelets with peripheral blood stem cells from unrelated donors: a comparison with marrow transplantation , 2000, Bone Marrow Transplantation.

[55]  D. Mcnulty,et al.  Identification of Unique Truncated KC/GROβ Chemokines with Potent Hematopoietic and Anti-Infective Activities , 2000, The Journal of Immunology.

[56]  B. Fingleton,et al.  Matrix metalloproteinases: biologic activity and clinical implications. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[57]  M. Le Bousse-Kerdilès,et al.  Chemokine SDF-1 enhances circulating CD34(+) cell proliferation in synergy with cytokines: possible role in progenitor survival. , 2000, Blood.

[58]  M. Martelli,et al.  Transplantation tolerance induced by "mega dose" CD34+ cell transplants. , 2000, Experimental hematology.

[59]  R. Alon,et al.  The chemokine SDF-1 stimulates integrin-mediated arrest of CD34(+) cells on vascular endothelium under shear flow. , 1999, The Journal of clinical investigation.

[60]  Y. Reisner,et al.  Induction of Donor-Type Chimerism and Transplantation Tolerance Across Major Histocompatibility Barriers in Sublethally Irradiated Mice by Sca-1+Lin− Bone Marrow Progenitor Cells: Synergism With Non-Alloreactive (Host × Donor)F1 T Cells , 1999 .

[61]  R. Willemze,et al.  Prevention of interleukin-8-induced mobilization of hematopoietic progenitor cells in rhesus monkeys by inhibitory antibodies against the metalloproteinase gelatinase B (MMP-9). , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[62]  H. Broxmeyer,et al.  Dominant Myelopoietic Effector Functions Mediated by Chemokine Receptor CCR1 , 1999, The Journal of experimental medicine.

[63]  B. Walker,et al.  Enhanced Inhibition of Human Immunodeficiency Virus Type 1 by Met-Stromal-Derived Factor 1β Correlates with Down-Modulation of CXCR4 , 1999, Journal of Virology.

[64]  J. Sipley,et al.  Activation of Matrix Metalloproteinase-9 (MMP-9) via a Converging Plasmin/Stromelysin-1 Cascade Enhances Tumor Cell Invasion* , 1999, The Journal of Biological Chemistry.

[65]  C. Figdor,et al.  Biology of IL‐8‐Induced Stem Cell Mobilization , 1999, Annals of the New York Academy of Sciences.

[66]  T. Springer,et al.  The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. , 1999, Immunity.

[67]  R. Alon,et al.  Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. , 1999, Science.

[68]  M. Martelli,et al.  Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. , 1998, The New England journal of medicine.

[69]  E. De Clercq,et al.  Processing by CD26/dipeptidyl‐peptidase IV reduces the chemotactic and anti‐HIV‐1 activity of stromal‐cell‐derived factor‐1α , 1998, FEBS letters.

[70]  S. Rafii,et al.  The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. , 1998, Blood.

[71]  Masahiko Kuroda,et al.  Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development , 1998, Nature.

[72]  C. Figdor,et al.  Anti-LFA-1 blocking antibodies prevent mobilization of hematopoietic progenitor cells induced by interleukin-8. , 1998, Blood.

[73]  M. Baggiolini.  Chemokines and leukocyte traffic , 1998, Nature.

[74]  G. Sledge,et al.  Myeloid progenitor cell proliferation and mobilization effects of BB10010, a genetically engineered variant of human macrophage inflammatory protein-1alpha, in a phase I clinical trial in patients with relapsed/refractory breast cancer. , 1998, Blood cells, molecules & diseases.

[75]  M. J. Kennedy,et al.  Peripheral Blood Progenitor Cell Mobilization: A Clinical Review , 1998, Pharmacotherapy.

[76]  Z. Werb.  ECM and Cell Surface Proteolysis: Regulating Cellular Ecology , 1997, Cell.

[77]  K. Matsushima,et al.  Enhanced mobilization of hematopoietic progenitor cells by mouse MIP‐2 and granulocyte colony‐stimulating factor in mice , 1997, Journal of leukocyte biology.

[78]  J. Cowland,et al.  Granules of the human neutrophilic polymorphonuclear leukocyte. , 1997, Blood.

[79]  R. Champlin,et al.  Factors affecting mobilization of CD34+ cells in normal donors treated with filgrastim , 1997, Transfusion.

[80]  L. To,et al.  The biology and clinical uses of blood stem cells. , 1997, Blood.

[81]  T. Springer,et al.  The Chemokine SDF-1 Is a Chemoattractant for Human CD34+ Hematopoietic Progenitor Cells and Provides a New Mechanism to Explain the Mobilization of CD34+ Progenitors to Peripheral Blood , 1997, The Journal of experimental medicine.

[82]  H. Broxmeyer,et al.  Involvement of Interleukin (IL) 8 receptor in negative regulation of myeloid progenitor cells in vivo: evidence from mice lacking the murine IL-8 receptor homologue , 1996, The Journal of experimental medicine.

[83]  D. Link,et al.  Impaired production and increased apoptosis of neutrophils in granulocyte colony-stimulating factor receptor-deficient mice. , 1996, Immunity.

[84]  R. Willemze,et al.  Improved survival of lethally irradiated recipient mice transplanted with circulating progenitor cells mobilized by IL-8 after pretreatment with stem cell factor. , 1996, Experimental hematology.

[85]  J. Gabrilove,et al.  Filgrastim (r-metHuG-CSF): the first 10 years. , 1996, Blood.

[86]  S. Nishikawa,et al.  Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1 , 1996, Nature.

[87]  R. Willemze,et al.  Rapid mobilization of hematopoietic progenitor cells in rhesus monkeys by a single intravenous injection of interleukin-8. , 1996, Blood.

[88]  L. Czaplewski,et al.  Mobilization of early hematopoietic progenitor cells with BB-10010: a genetically engineered variant of human macrophage inflammatory protein-1 alpha. , 1995, Blood.

[89]  R. Willemze,et al.  Interleukin-8 induces rapid mobilization of hematopoietic stem cells with radioprotective capacity and long-term myelolymphoid repopulating ability. , 1995, Blood.

[90]  N. Schmitz,et al.  Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor) , 1995, Blood.

[91]  F. Appelbaum,et al.  Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor , 1993 .

[92]  J. Armitage,et al.  The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies. , 1991, Blood.

[93]  T. Springer,et al.  Contributions of the Mac-1 glycoprotein family to adherence-dependent granulocyte functions: structure-function assessments employing subunit-specific monoclonal antibodies. , 1986, Journal of immunology.

[94]  W. Robinson,et al.  Colony Growth of Human Peripheral White Blood Cells In Vitro , 1971 .

[95]  D. Boggs,et al.  In vitro growth of granulocytic and mononuclear cell colonies from blood of normal individuals. , 1971, Blood.

[96]  E. Hersh,et al.  Cells Capable of Colony Formation in the Peripheral Blood of Man , 1971, Science.

[97]  S. Fukuda,et al.  Neutrophil-derived MMP-9 mediates synergistic mobilization of hematopoietic stem and progenitor cells by the combination of G-CSF and the chemokines GROβ/CXCL2 and GROβT /CXCL2Δ4 , 2004 .

[98]  M. Horowitz,et al.  The International Bone Marrow Transplant Registry , 2002, International journal of hematology.

[99]  E. Thomas,et al.  A review of autologous hematopoietic cell transplantation. , 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[100]  C. Figdor,et al.  The role of metalloproteinases and adhesion molecules in interleukin-8-induced stem-cell mobilization. , 2000, Seminars in hematology.

[101]  H. Broxmeyer,et al.  In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants: stromal cell-derived factor-1, steel factor, and the bone marrow environment. , 1998, Blood.

[102]  H. Birkedal‐Hansen,et al.  Matrix metalloproteinases: a review. , 1993, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.